After receiving a drug rejection from the FDA, Woburn-based Replimune Group (Nasdaq: REPL) has informed the state that it ...
The combined company will operate as Obsidian Therapeutics following the merger. Investors in the $350 million private ...
Choosing the right hosting can speed up your website. Dedicated and cloud hosting give you more control over server resources ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results